Revenue segments as reported by the company.

Premiums

Product revenue

Administrative fees and other revenue

Net investment income

Net gains on financial instruments

Gain on sale of business

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Benefit expense

Selling, general and administrative

Interest expense

Amortization of other intangible assets

Loss on extinguishment of debt

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Elevance Health Inc

Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. The firm supports consumers, families, and communities across the entire care journey, connecting them to the care, support, and resources they need to lead healthier lives. It offers health plans and clinical, behavioral, pharmacy, and complex-care solutions which promote whole health. The company was founded in 1944 and is headquartered in Indianapolis, IN.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Elevance Health reports robust Q4 earnings, eyes margin optimization

Elevance Health's strong Q4 2022 performance, strategic acquisitions, and focus on margin optimization position the company for continued growth. With a clear outlook for 2023, emphasizing membership expansion and margin recovery, the company is poised for success. Challenges in optimizing margins and managing cost structures are balanced by growth opportunities and strategic initiatives.

Elevance Health reports robust Q1 growth and innovation in healthcare

Elevance Health Inc demonstrated strong financial performance and growth in Q1 2023, driven by increased membership and solid operating results.
The company's focus on advocacy, innovation, and sustainability, along with strategic investments in healthcare capabilities, positions it for continued success.
While facing challenges in cost management and strategic partnerships, Elevance Health is well-positioned to capitalize on opportunities in specialty care and value-based models.
Overall, Elevance Health's commitment to whole health, innovation, and value-based care sets a positive trajectory for future growth and industry leadership.

Elevance Health Inc posts robust Q2 earnings, eyes value-based care

Elevance Health Inc reported strong Q2 earnings, raised adjusted EPS outlook to over $32.85 for the year, and emphasized a focus on value-based care and digital solutions. While facing margin pressure in Carelon, the company remains confident in its strategy execution and performance for 2023 and beyond.

Elevance Health excels in Q3, eyes growth through strategic actions

Elevance Health's Q3 performance was strong, with a focus on operational efficiency and strategic investments. Challenges in Medicare ratings were addressed through proactive measures, while opportunities lie in growth acceleration and strategic partnerships. The company remains on track to achieve its long-term growth targets.

Elevance Health Inc surpasses earnings expectations, eyes growth opportunities

Elevance Health Inc's strong financial performance in Q4 2023 and full-year results, coupled with strategic initiatives in expanding capabilities and enhancing operational efficiency, position the company for continued success. Challenges in commercial repricing and Medicaid dynamics are being addressed, while opportunities in Medicare Advantage and strategic investments offer avenues for growth.

Elevance Health posts robust Q1 earnings, eyes strategic growth

Elevance Health demonstrated strong financial performance in Q1, with revenue growth and margin expansion in key segments.
While facing challenges like potential Medicare rate cuts, the company is leveraging partnerships and acquisitions for growth.
Opportunities lie in expanding service offerings, geographic footprint, and optimizing Medicaid margins for long-term sustainability.

Elevance Health Inc reports robust earnings growth and strategic wins

Elevance Health's Q2 performance reflects strong earnings growth and reaffirmed guidance, driven by solid segment performance and new business wins.
The company's strengths lie in its high Medicare rating, robust revenue growth in services, and strategic focus on value creation.
Challenges include sustaining growth momentum, managing funding cuts, and effectively integrating recent acquisitions for long-term success.
Opportunities exist in accelerating capabilities, expanding market share, optimizing operations, and leveraging workplace recognition for talent attraction and innovation.

Elevance Health faces Medicaid challenges, sees growth in AI investments

Elevance Health's Q3 earnings were impacted by elevated medical costs in Medicaid, leading to a reduction in full-year outlook. Despite challenges in the Medicaid business, the company's Medicare Advantage and Commercial businesses are performing well. Investments in AI and expansion of Carelon Services present growth opportunities.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. It operates through the following segments: Commercial and Specialty Business, Government Business, CarelonRx, and Other. The Commercial and Specialty Business segment provides insurance products and services such as stop loss, dental, vision, life, disability and supplemental health insurance. The Government Business segment includes medicare and medicaid businesses, national government services, and services provided to the federal government. The CerelonRx segment offers formulary management, pharmacy networks, prescription drug database, member services, and mail order capabilities. The Other segment is involved in health services business focused on quality of healthcare by enabling and creating new care delivery and payment models. The company was founded in 1944 and is headquartered in Indianapolis, IN.

Cigna

Shares of several health insurers rallied in trading on Friday after UnitedHealth Group Inc. UNH, +1.79% reported better-than-expected profit and revenue in the fourth quarter of 2022. Elevance Health Inc.'s ELV, +2.52% stock was up 2.6%, while shares of Cigna Corp. CI, +2.24% gained 2.2%, and shares of CVS Health Corp. CVS, +1.21% , which owns Aetna, were up 1.1%.

Elevance Health, Cigna's stocks gain

INDIANAPOLIS--( BUSINESS WIRE )--Elevance Health (NYSE: ELV) will release fourth quarter 2022 financial results on January 25, 2023, at 6:00 a.m. Eastern Standard Time (“EST”). Management will review these results and its outlook during a conference call at 8:30 a.m. EST that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers:

Elevance Health to Hold Conference Call and Webcast to Discuss Fourth Quarter Results on January 25, 2023

Elevance Health (ELV) remains well-poised for growth due to a growing customer base within its Government and IngenioRx businesses coupled with solid cash-generating abilities.

Why You Should Hold Elevance Health (ELV) in Your Portfolio

The Health Care sector is favored by many analysts in 2023 for its somewhat insulated profit growth. One large-cap in the managed health care industry sports double-digit EPS growth in the years ahead.

Elevance Health: Strong And Steady EPS Growth Ahead, High Relative Strength Name

Bank of America

British American Tobacco

Caterpillar

Alphabet

JPMorgan Chase & Co

Robert Half Int.

Starbucks

Tyson Foods

Texas Instruments

Union Pacific

Visa

No matter your investor profile, sector needs, or approach, there should be something of interest to be found here. I highlight ten companies for the dividend investor across many different sectors with both high and low initial yields while painted in the picture of my 2023 outlook.

My Top 10 Dividend Companies To Watch Out For In 2023

Progyny

ELV vs. PGNY: Which Stock Is the Better Value Option?

Health care has been a nightmare of a place to invest in over the last year. One area of the health care space that has withstood the sharp declines, however, are those companies that operate in the managed plans area of the sector.

Elevance: A Standout Health Care Stock

Centene

T-Mobile US

Viking Global Investors LP, the firm founded by Andreas Halvorsen (Trades, Portfolio), disclosed in a regulatory filing that its top five trades during the third quarter included the closure of its position in Centene Corp. ( CNC , Financial) and American International Group Inc. ( AIG , Financial), a reduction to its holding of T-Mobile US Inc. ( TMUS , Financial) and boosts to its investments in Visa Inc. ( V , Financial) and Elevance Health Inc. ( ELV , Financial).

Andreas Halvorsen's Top 5 Trades of the 3rd Quarter

Archer-Daniels-Midland Company

Marathon Petroleum

Large-cap stocks are a staple in every portfolio. They're well-established, have greater analyst coverage, typically pay dividends, and help shield investors from volatility.

3 Top-Ranked Large-Caps With Big Growth

Amgen

CVS Health

Home Depot

Wells Fargo

The third quarter of 2022 was another discouraging period for investors. Inflation kept going strong, the Federal Reserve continued raising interest rates and even the housing market began showing signs of weakness as consumers were slammed by the combination of rising costs and increasing mortgage rates.

The Most-Sold Guru Stocks of the 3rd Quarter

Elevance Health (ELV) continues to benefit from sustained top-line growth, higher membership in Government business and a sturdy financial position.

Factors That Make Elevance Health (ELV) a Lucrative Bet Now

ELV vs. PGNY: Which Stock Should Value Investors Buy Now?

INDIANAPOLIS--( BUSINESS WIRE )--Elevance Health, Inc. (NYSE: ELV) announced today that 21 of its affiliated Medicaid plans are the first in the nation to earn a full three-year accreditation for health equity from the National Committee for Quality Assurance (NCQA). The accreditation demonstrates Elevance Health's commitment to advancing health equity and prioritizing the whole health needs of entire communities of people who have been historically marginalized, economically and socially.

Twenty-one Elevance Health Medicaid Plans Receive NCQA Health Equity Accreditation

Apple

Johnson & Johnson

MercadoLibre

QUALCOMM

Raytheon Technologies

Walmart

Large-cap stocks are always great to have in a portfolio. These companies are some of the biggest and best-known stocks in the market.

7 Top-Rated Large-Cap Stocks to Buy and Hold

Elevance Health (ELV) reported earnings 30 days ago. What's next for the stock?

Why Is Elevance Health (ELV) Down 5% Since Last Earnings Report?

INDIANAPOLIS--( BUSINESS WIRE )--As part of their ongoing commitment to equity and providing support for women and women's health, Elevance Health has partnered with national nonprofit Impact Fitness Foundation to create a fitness and movement space at Herron-Riverside High School, in celebration of the inaugural Elevance Health Women's Fort Myers Tipoff, a pre-season women's collegiate basketball tournament.

Elevance Health Teams Up with the Impact Fitness Foundation to Support Herron-Riverside High School

Elevance Health (ELV) is well positioned to outperform the market, as it exhibits above-average growth in financials.

3 Reasons Growth Investors Will Love Elevance Health (ELV)

ELV or PGNY: Which Is the Better Value Stock Right Now?

INDIANAPOLIS--(BUSINESS WIRE)---- $ELV--Elevance Health (NYSE: ELV) today announced that it has entered into an agreement with CarepathRx, a portfolio company of Nautic Partners, to acquire BioPlus, a comprehensive specialty pharmacy.

Elevance Health to Acquire BioPlus

INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health (NYSE: ELV) announced today that senior management is scheduled to present at the 4th Annual Wolfe Research Healthcare Conference in New York City on November 16, at 10:00 a.m.

Elevance Health Announces Appearance at 4th Annual Wolfe Research Healthcare Conference

This managed care business will benefit from the growing demand for health insurance.

Buy This Blue Chip Stock Today and Thank Yourself Later

INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health (NYSE: ELV) announced today that senior management is scheduled to present at the 31st Annual Credit Suisse Healthcare Conference in Rancho Palos Verdes, California on November 9, at 11:35 a.m.

Elevance Health Announces Appearance at Upcoming Conference

Elevance Health (ELV) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Elevance Health, Inc. (ELV) Hit a 52 Week High, Can the Run Continue?

This insurance stock hit buy a point on the chart and is in the buy zone. The stock has taken off since its positive Q3 earnings report.

Insurance Stock Hits New High To Key Level

Humana

McKesson

All three stocks are up double-digit percentages in 2022, leaving the S&P 500's performance in the dust. With the stocks carrying favorable near-term earnings outlooks, the run could easily continue.

News for Elevance Health Inc Stock (ELV)